Share to
Share to
Test ID:
BORMIYGM S
Borrelia miyamotoi Antibodies (IgG and IgM), Serum
Test Overview
Clinical Utility
Borrelia miyamotoi is a tick-borne bacterial organism that causes a nonspecific febrile illness that may be misdiagnosed as Lyme disease or other tick-borne infections. Positive antibody results suggest B. miyamotoi infection; however, other tick-borne organisms may induce cross-reactive antibodies. Negative IgG and IgM results do not exclude the possibility of B. miyamotoi infection.
Method
Immunoassay (IA)
Result Included
B. miyamotoi Ab (IgG); B. miyamotoi Ab (IgM)
Aliases/Synonyms
GLPQ; B. miyamotoi
Specimen
Specimen Type
SerumContainers
Collection Containers
Gold top (clot activator & gel)
Volume
Sample Volume
1.5 mL
Minimum Volume
0.5 mL
Collection & Handling
Handling Information
Store and send cold or frozen.
Stability
| Ambient | Refrigerated | Frozen |
|---|---|---|
| 7 days | 14 days | 30 days |
Rejection Criteria
| Criteria | Specification |
|---|---|
| Hemolysis | Gross |
| Lipemia | Gross |
| Icterus | Gross |
Performance & Interpretation
Turnaround Time
7 days
Results
Name
Units
Reference Range
Conversion
-
B. miyamotoi Ab (IgG)Index< 1.00
-
B. miyamotoi Ab (IgM)Index< 1.00
Referral Location
Out-of-Country
Interface & Setup
HL7 Interface Codes
| Order Code | Result Name | Result Codes | Units |
|---|---|---|---|
| BORMIYGM S | B. MIYAMOTOI AB (IGG) | 65183 | INDEX |
| B. MIYAMOTOI AB (IGM) | 65184 | INDEX | |
| INTERPRETATION | 65185 |
Test Version
Last Updated
2023-08-18